EOJOAM
E. Ohman J:or Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
5,700
-100
| -2% | -$32.6K | 0.05% | 183 |
|
|
2025
Q1 | $1.57M | Sell |
5,800
-300
| -5% | -$81K | 0.04% | 204 |
|
|
2024
Q4 | $1.44M | Buy |
6,100
+700
| +13% | +$165K | 0.03% | 221 |
|
|
2024
Q3 | $1.49M | Buy |
+5,400
| New | +$1.49M | 0.04% | 204 |
|
|
2023
Q3 | – | Sell |
-2,000
| Closed | -$380K | – | 420 |
|
|
2023
Q2 | $380K | Hold |
2,000
| – | – | 0.01% | 390 |
|
|
2023
Q1 | $401K | Buy |
+2,000
| New | +$401K | 0.02% | 380 |
|
|
2022
Q1 | – | Sell |
-6,400
| Closed | -$1.09M | – | 427 |
|
|
2021
Q4 | $1.09M | Buy |
+6,400
| New | +$1.09M | 0.03% | 286 |
|
|
2021
Q2 | – | Sell |
-2,500
| Closed | -$353K | – | 463 |
|
|
2021
Q1 | $353K | Hold |
2,500
| – | – | 0.01% | 392 |
|
|
2020
Q4 | $325K | Hold |
2,500
| – | – | 0.01% | 379 |
|
|
2020
Q3 | $364K | Buy |
+2,500
| New | +$364K | 0.02% | 328 |
|
|
2020
Q2 | – | Sell |
-2,300
| Closed | -$250K | – | 432 |
|
|
2020
Q1 | $250K | Sell |
2,300
-900
| -28% | -$98K | 0.02% | 328 |
|
|
2019
Q4 | $369K | Buy |
+3,200
| New | +$369K | 0.02% | 351 |
|
|
2018
Q2 | – | Sell |
-2,200
| Closed | -$262K | – | 379 |
|
|
2018
Q1 | $262K | Hold |
2,200
| – | – | 0.02% | 394 |
|
|
2017
Q4 | $280K | Buy |
+2,200
| New | +$280K | 0.02% | 417 |
|
|
2016
Q4 | – | Sell |
-1,600
| Closed | -$108K | – | 552 |
|
|
2016
Q3 | $108K | Hold |
1,600
| – | – | 0.02% | 495 |
|
|
2016
Q2 | $88.8K | Hold |
1,600
| – | – | 0.01% | 496 |
|
|
2016
Q1 | $100K | Hold |
1,600
| – | – | 0.02% | 481 |
|
|
2015
Q4 | $151K | Hold |
1,600
| – | – | 0.03% | 417 |
|
|
2015
Q3 | $129K | Hold |
1,600
| – | – | 0.03% | 430 |
|
|
2015
Q2 | $192K | Buy |
+1,600
| New | +$192K | 0.04% | 367 |
|